The UAE's Ministry of Health and Prevention (MoHAP) has unveiled a 15-minute rapid blood test that can evaluate mild Traumatic Brain Injury (mTBI).
With 95.8 per cent sensitivity, it will enable faster treatment for the injured persons and is the world’s first US Food And Drug Administration (USFDA)-approved blood test.
The announcement at the Arab Health 2021 highlighted the partnership between the UAE health authority and Abbot labs.
Designed to run on a handheld i-STAT Alinity platform, the test requires a small blood sample drawn from the arm to measure specific proteins present in the blood after an mTBI.
A negative result on this test can be used to rule out the need for a head CT scan, while a positive result complements CT scans to help clinicians evaluate whether someone has an mTBI.
Dr. Youssef Mohamed Al Serkal, Director-General of the Emirates Health Services (EHS), said this is one of the most important diagnostic tests that help in detecting mild brain injuries, which usually occur after falling down or experiencing car accidents.
He explained that this new technology will help clinicians assess and detect brain injuries and concussions as fast as possible with accurate results.


UAE President to begin state visit to Germany on Wednesday
Sheikh Mansour approves family charter to protect children after divorce
UAE flights to Jakarta face disruptions due to volcanic ash
UAE launches programme to empower Emirati youth address water challenges
H.H. Sheikh Mohammed pays tribute to UAE President in new book
Falcon sets world auction record at AED2.1 million in Abu Dhabi
UAE expresses solidarity with Greece over death of two pilots in plane crash
UAE joins 7 other countries in rejecting displacement of Palestinians from Gaza
